Three Markets, Two Weeks: Strengthening MORENOVA’s Presence Across APAC

October 2026

INITIA team and partners during clinical and market development activities in APAC

Over the course of two weeks, the INITIA team, led by Oren Barashi, VP Sales & Business Development, continued strengthening the company’s presence across APAC through clinical education, academic engagement, and local market development in Hong Kong, Singapore, and India.

Hong Kong: Clinical Engagement and Research Collaboration

Together with local partner GBHK, INITIA participated in a focused CME programme covering Men’s Health and Women’s Health, providing an opportunity to engage directly with clinicians and discuss the role of MORENOVA in clinical practice.

The visit also included meetings at The Hong Kong Polytechnic University (PolyU), where discussions with Prof. Shirley Ngai and Dr. Howard Fong explored potential clinical evaluation and research collaboration in rehabilitation, musculoskeletal care, and wound healing.

Singapore: Education and Clinical Adoption

In Singapore, INITIA joined Porshin Ng and the AXONVIS team at ANDROCOURSE 2026, combining focused workshops and clinical presentations for physicians in Andrology, Urology, and Men’s Health.

The programme gave participants a closer look at MORENOVA and supported practical discussions around clinical adoption, treatment workflows, and the role of advanced shockwave technology in everyday practice.

India: Long-Term Market Development

In India, meetings with potential partners, clinicians, and academic stakeholders focused on long-term market development, clinical evaluation, and future research collaboration.

The trip concluded with INITIA’s participation in the World Physiotherapy Asia Western Pacific Region Conference 2026 in New Delhi, creating another opportunity to engage with healthcare professionals and explore future collaboration in physiotherapy and rehabilitation.

Building MORENOVA’s Presence Across APAC

Each market requires a different approach, but the foundation remains consistent: clinical adoption, academic engagement, and strong local partnerships.

Through this combination of education, research collaboration, and market development, INITIA continues to build a stronger and more sustainable presence for MORENOVA across APAC.